Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous intravenous insulin therapy with a miniaturized open-loop system.

R Renner, K D Hepp, H Mehnert

    Hormone and Metabolic Research. Supplement Series
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Diabetes mellitus and periodontitis. Bidirectional relationship and clinical implications. A consensus document].

    Der Internist·2011
    Same author

    [Challenge in diabetes therapy: effects of glitazones beyond blood glucose control].

    Deutsche medizinische Wochenschrift (1946)·2009
    Same author

    Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy: efficacy of rosiglitazone.

    Diabetic medicine : a journal of the British Diabetic Association·2005
    Same author

    Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications.

    Diabetes & metabolism·2005
    Same author

    Combined oral therapy for type 2 diabetes.

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2004
    Same author

    [Delaying and preventing type 2 diabetes mellitus].

    MMW Fortschritte der Medizin·2004

    Portable open-loop insulin systems significantly improve blood glucose control in diabetics. These systems offer a promising approach for better metabolic management compared to conventional insulin therapy.

    Area of Science:

    • Endocrinology
    • Medical Devices
    • Diabetes Management

    Background:

    • Conventional insulin therapy presents challenges in achieving optimal metabolic control for insulin-requiring diabetics.
    • Juvenile-type and brittle-type diabetes often exhibit significant glycemic variability.

    Purpose of the Study:

    • To evaluate the efficacy of a portable open-loop insulin infusion system for continuous subcutaneous insulin delivery.
    • To compare the metabolic control achieved by the open-loop system against conventional subcutaneous insulin therapy.

    Main Methods:

    • Development of a portable open-loop system with a miniaturized pump, insulin reservoir, and electronic control unit.
    • Testing infusion rates that were either preprogrammed or patient-controlled.
    • Comparison of glycemic control metrics (mean blood glucose, mean amplitude of glycemic excursions, glucosuria) over 2-3 days of continuous infusion versus a 1-2 day pre-infusion period in eight juvenile-type diabetics.

    Related Experiment Videos

    Main Results:

    • All patients demonstrated significantly better glycemic control with the open-loop systems compared to conventional therapy.
    • Key indicators including mean blood glucose (MBG) and mean amplitude of glycemic excursions (MAGE) showed marked improvement.
    • Reduced glucosuria was observed, indicating enhanced overall metabolic regulation.

    Conclusions:

    • Portable open-loop insulin systems represent a promising advancement in diabetes management.
    • These systems offer a viable strategy for improving metabolic control in patients requiring insulin therapy.
    • The study highlights the potential of continuous insulin infusion technology for better diabetes care.